- The Mentors, The Social Support and Patients with Diabetes Mellitus
-
Park YJ
- KMID: 2451841
- J Korean Diabetes.
- 2019 Jun;20(2):112-116.
- doi: 10.4093/jkd.2019.20.2.112
In countries with advanced health practices, it is important to note the importance of social capital and social support as social determinants in patient health as early as possible, while... -
- CITED
-
- Close
- SHARE
-
- Close
- Intake of Fruits for Diabetics: Why and How Much?
-
Lee EY
- KMID: 2451840
- J Korean Diabetes.
- 2019 Jun;20(2):106-111.
- doi: 10.4093/jkd.2019.20.2.106
Fruits are universally promoted as healthy. Fruits supply dietary fiber, vitamins, minerals and phytochemicals that function as antioxidants. But many people often have concerns that fruit intake has a negative... -
- CITED
-
- Close
- SHARE
-
- Close
- Sodium-Glucose Cotransporter 2 Inhibitors for People with Type 1 Diabetes
-
Kim CH, Moon JS
- KMID: 2451838
- J Korean Diabetes.
- 2019 Jun;20(2):92-98.
- doi: 10.4093/jkd.2019.20.2.92
Althowgh intensive insulin regimen is the main treatment in people with type 1 diabetes, glucose variability and weight gain remain as challenges for this treatment. Sodium-glucose cotransporter (SGLT) inhibitors (including... -
- CITED
-
- Close
- SHARE
-
- Close
- Education of Patients with Diabetes Mellitus and Peripheral Artery Disease
-
Yun HR
- KMID: 2451839
- J Korean Diabetes.
- 2019 Jun;20(2):99-105.
- doi: 10.4093/jkd.2019.20.2.99
Peripheral artery disease (PAD) and diabetes increase the risk of significant morbidity and mortality and can affect quality of life. PAD is a progressive disease, and the presence of diabetes... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevention of Major Adverse Cardiovascular and Renal Outcomes with Sodium-Glucose Cotransporter 2 Inhibitors
-
Hong JH
- KMID: 2451837
- J Korean Diabetes.
- 2019 Jun;20(2):87-91.
- doi: 10.4093/jkd.2019.20.2.87
Management of hyperglycemia limits progression of microvascular complications in type 2 diabetes mellitus (T2DM). According to large-scale randomized control studies to demonstrate the cardiovascular safety of sodium-glucose cotransporter 2 (SGLT2)... -
- CITED
-
- Close
- SHARE
-
- Close
- Sodium-Glucose Cotransporter 2 Inhibitors: Mechanisms of Action and Various Effects
-
Kim KS
- KMID: 2451835
- J Korean Diabetes.
- 2019 Jun;20(2):74-80.
- doi: 10.4093/jkd.2019.20.2.74
The basic action mechanism of sodium-glucose cotransporter 2 (SGLT2) inhibitor is to lower the glucose burden by excreting the glucose filtered by the kidney into the urine. Although SGLT2 inhibitors... -
- CITED
-
- Close
- SHARE
-
- Close
- Saxenda® Frenzy: Opinions of an Endocrine and Metabolism Specialist
-
Kim S
- KMID: 2451833
- J Korean Diabetes.
- 2019 Jun;20(2):63-66.
- doi: 10.4093/jkd.2019.20.2.63
Globally, the problem of obesity is increasing, and the prevalence of obesity in Korea is also rising rapidly. Obesity is a risk factor for cardiometabolic diseases including type 2 diabetes... -
- CITED
-
- Close
- SHARE
-
- Close
- Connections between Diabetes and Cognitive Dysfunction
-
Lee SH
- KMID: 2451834
- J Korean Diabetes.
- 2019 Jun;20(2):67-73.
- doi: 10.4093/jkd.2019.20.2.67
Dementia, a clinical syndrome affecting memory, thinking, and social abilities primarily caused by neurodegeneration, is becoming one of the greatest health and socioeconomic burdens in the aging society. The age-standardized... -
- CITED
-
- Close
- SHARE
-
- Close
- The Potential Cardioprotective Mechanism of Sodium-Glucose Cotransporter 2 Inhibitors
-
Jeon JH
- KMID: 2451836
- J Korean Diabetes.
- 2019 Jun;20(2):81-86.
- doi: 10.4093/jkd.2019.20.2.81
The potential mechanism by which sodium-glucose cotransporter 2 (SGLT2) inhibitors prevent cardiovascular disease (CVD) is being widely investigated. Improved insulin resistance, along with decreased body fat mass associated with SGLT2... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic Effect of Quadruple Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus Who Have Insulin Limitations
-
Yoo WS, Kim DH, Kim HJ, Chung HK
- KMID: 2451842
- J Korean Diabetes.
- 2019 Jun;20(2):117-126.
- doi: 10.4093/jkd.2019.20.2.117
BACKGROUND: Insulin therapy is the treatment of choice in type 2 diabetes mellitus (T2DM) patients who are not achieving glycemic goals despite triple oral hypoglycemic agent (OHA) combination therapy. However,... -
- CITED
-
- Close
- SHARE
-
- Close
